Literature DB >> 15937756

Integrons: adding another threat to the use of antibiotic therapy.

S Ragnar Norrby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15937756     DOI： 10.1086/430715

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Antibiotic resistance and carriage class I integron in clinical isolates of Acinetobacter baumannii from Al Muthanna, Iraq.

Authors:  Yasir Adil Jabbar Alabdali
Journal:  J Antibiot (Tokyo)       Date:  2022-10-04       Impact factor: 3.424

2.  Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.

Authors:  George L Daikos; Chris Kosmidis; Panayotis T Tassios; George Petrikkos; Alexandra Vasilakopoulou; Mina Psychogiou; Ioanna Stefanou; Athina Avlami; Nikolaos Katsilambros
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

3.  Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals.

Authors:  Aarati N Rao; Miriam Barlow; Leigh Ann Clark; John R Boring; Fred C Tenover; John E McGowan
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

4.  Within-Host and Population Transmission of blaOXA-48 in K. pneumoniae and E. coli.

Authors:  Manon R Haverkate; Mirjam J D Dautzenberg; Tjaco J M Ossewaarde; Anneke van der Zee; Jan G den Hollander; Annet Troelstra; Marc J M Bonten; Martin C J Bootsma
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

5.  Distribution of Integrons and Phylogenetic Groups among Enteropathogenic Escherichia coli Isolates from Children <5 Years of Age in Delhi, India.

Authors:  Taru Singh; Shukla Das; V G Ramachandran; Sayim Wani; Dheeraj Shah; Khan A Maroof; Aditi Sharma
Journal:  Front Microbiol       Date:  2017-04-10       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.